These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


166 related items for PubMed ID: 6781389

  • 1. Neutralizing capacity and cost effectiveness of antacids.
    Drake D, Hollander D.
    Ann Intern Med; 1981 Feb; 94(2):215-7. PubMed ID: 6781389
    [Abstract] [Full Text] [Related]

  • 2. Evaluation of buffering capacity and acid neutralizing-pH time profile of antacids.
    Lin MS, Sun P, Yu HY.
    J Formos Med Assoc; 1998 Oct; 97(10):704-10. PubMed ID: 9830281
    [Abstract] [Full Text] [Related]

  • 3. Evaluation of antacid suspensions containing aluminum hydroxide and magnesium hydroxide.
    Hem SL, White JL, Buehler JD, Luber JR, Grim WM, Lipka EA.
    Am J Hosp Pharm; 1982 Nov; 39(11):1925-30. PubMed ID: 7148862
    [Abstract] [Full Text] [Related]

  • 4. Acid-neutralizing capacity and sodium content of antacid products from Belgium.
    Gombatz VW.
    Clin Ther; 1984 Nov; 6(2):151-4. PubMed ID: 6705010
    [Abstract] [Full Text] [Related]

  • 5. Effect of composition on the neutralizing properties of antacid preparations.
    Pawlaczyk J, Lutka A, Kokot Z.
    Pharmazie; 1984 May; 39(5):334-6. PubMed ID: 6473495
    [Abstract] [Full Text] [Related]

  • 6. In vitro comparison of the antacid potencies of almagate in tablets and suspension with those of other commercially available antacid preparations.
    Prieto R, Martinez-Tobed A, Fábregas JL, Beneyto JE.
    Arzneimittelforschung; 1984 May; 34(10A):1360-4. PubMed ID: 6548920
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. In vitro evaluation of liquid antacid products.
    Sherrill MC, Rudd GD.
    Am J Hosp Pharm; 1982 Feb; 39(2):300-2. PubMed ID: 7058802
    [Abstract] [Full Text] [Related]

  • 9. [Determination of formulation quantities for three kinds of antacid using triangle coordinates].
    Sofue M, Ueda Y, Yamamoto M, Yamasaki T, Manabe T.
    Yakugaku Zasshi; 1997 Mar; 117(3):185-92. PubMed ID: 9109346
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Effect of food on antacid neutralizing capacity in man.
    Halter F, Huber R, Häcki WH, Varga L, Bachmann C.
    Eur J Clin Invest; 1982 Jun; 12(3):209-17. PubMed ID: 6809470
    [Abstract] [Full Text] [Related]

  • 12. The evaluation of antacid value of magnesium-aluminium trisilicate dihydrate tablets.
    Jovanović M, Todorović G, Djurić Z, Bulajić V.
    Pharmazie; 1985 Nov; 40(11):807. PubMed ID: 4095135
    [No Abstract] [Full Text] [Related]

  • 13. The neutralizing capacity and sodium content of antacid brands on the Kenyan market.
    Kibwage IO, Machine A, Hagos B, Hoogmartens J.
    East Afr Med J; 1995 Mar; 72(3):194-7. PubMed ID: 7796775
    [Abstract] [Full Text] [Related]

  • 14. Antacid activity of calcium carbonate and hydrotalcite tablets. Comparison between in vitro evaluation using the "artificial stomach-duodenum" model and in vivo pH-metry in healthy volunteers.
    Vatier J, Ramdani A, Vitré MT, Mignon M.
    Arzneimittelforschung; 1994 Apr; 44(4):514-8. PubMed ID: 8011006
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Characterization of antacid compounds containing both aluminum and magnesium. I. Crystalline powders.
    Peterson CL, Perry DL, Masood H, Lin H, White JL, Hem SL, Fritsch C, Haeusler F.
    Pharm Res; 1993 Jul; 10(7):998-1004. PubMed ID: 8378263
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 9.